LB19. Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants

BACKGROUND: RSV is the leading cause of infant LRTI and hospitalization worldwide. The greatest burden of severe disease is in term infants <5 months old. Novavax is developing an aluminum-adjuvanted RSV F nanoparticle vaccine for use in the third trimester of pregnancy, with the goal of preventi...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Fries, Louis, Thomas, D Nigel, Smith, Gale, Plested, Joyce, Piedra, Pedro, Patel, Nita, Cho, Iksung, Glenn, Greg
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254636/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy229.2193
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料